These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 9261743

  • 1. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
    Tsukada N, Aoki S, Maruyama S, Kishi K, Takahashi M, Aizawa Y.
    J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
    [Abstract] [Full Text] [Related]

  • 2. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT, Mallet F, Chambost H, Sainty D, Gastaut JA, Olive D.
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [Abstract] [Full Text] [Related]

  • 4. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM.
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [Abstract] [Full Text] [Related]

  • 5. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
    Subauste CS, de Waal Malefyt R, Fuh F.
    J Immunol; 1998 Feb 15; 160(4):1831-40. PubMed ID: 9469444
    [Abstract] [Full Text] [Related]

  • 6. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells.
    Li H, Liu ZH, Dai CS, Liu D, Li LS.
    Acta Pharmacol Sin; 2002 Sep 15; 23(9):775-81. PubMed ID: 12230943
    [Abstract] [Full Text] [Related]

  • 7. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G.
    Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221
    [Abstract] [Full Text] [Related]

  • 8. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
    Love KS, Lakshmanan RR, Butterfield JH, Fox CC.
    Cell Immunol; 1996 May 25; 170(1):85-90. PubMed ID: 8660803
    [Abstract] [Full Text] [Related]

  • 9. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.
    Eur J Immunol; 1998 Jan 25; 28(1):90-103. PubMed ID: 9485189
    [Abstract] [Full Text] [Related]

  • 10. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
    Smythe JA, Fink PD, Logan GJ, Lees J, Rowe PB, Alexander IE.
    J Immunol; 1999 Sep 15; 163(6):3239-49. PubMed ID: 10477593
    [Abstract] [Full Text] [Related]

  • 11. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 12. Expression of major histocompatibility complex class II and costimulatory molecules in oral carcinomas in vitro.
    Villarroel-Dorrego M, Speight PM, Barrett AW.
    Med Oral Patol Oral Cir Bucal; 2005 Jan 15; 10(3):188-95. PubMed ID: 15876961
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells.
    Yokozeki H, Katayama I, Ohki O, Arimura M, Takayama K, Matsunaga T, Satoh T, Umeda T, Azuma M, Okumura K, Nishioka K.
    Br J Dermatol; 1997 Jun 15; 136(6):831-7. PubMed ID: 9217813
    [Abstract] [Full Text] [Related]

  • 14. High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress.
    Byrne SN, Halliday GM.
    Cancer Immunol Immunother; 2003 Jun 15; 52(6):396-402. PubMed ID: 12739069
    [Abstract] [Full Text] [Related]

  • 15. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 15; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 16. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
    Foreman KE, Wrone-Smith T, Krueger AE, Nickoloff BJ.
    Clin Immunol; 1999 Jun 15; 91(3):345-53. PubMed ID: 10370381
    [Abstract] [Full Text] [Related]

  • 17. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma.
    Tatsumi T, Takehara T, Katayama K, Mochizuki K, Yamamoto M, Kanto T, Sasaki Y, Kasahara A, Hayashi N.
    Hepatology; 1997 May 15; 25(5):1108-14. PubMed ID: 9141426
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
    Ugurel S, Uhlig D, Pföhler C, Tilgen W, Schadendorf D, Reinhold U.
    Cancer Immunol Immunother; 2004 Jun 15; 53(6):551-9. PubMed ID: 14727087
    [Abstract] [Full Text] [Related]

  • 19. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
    Guerder S, Eynon EE, Flavell RA.
    J Immunol; 1998 Sep 01; 161(5):2128-40. PubMed ID: 9725204
    [Abstract] [Full Text] [Related]

  • 20. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR.
    J Am Soc Nephrol; 2005 Jul 01; 16(7):2012-22. PubMed ID: 15944341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.